×
Palliative Dehydration PDF
$ 40.00
Palliative Dehydration PDF quantity
$ 40.00
×
Factors Associated With Medication Adherence in African American and White Patients With Bipolar Disorder PDF
$ 40.00
Factors Associated With Medication Adherence in African American and White Patients With Bipolar Disorder PDF quantity
$ 40.00
×
Commentary: Concerns Regarding the Inclusion of Temper Dysregulation Disorder With Dysphoria in the Diagnostic and Statistical Manual of Mental Disorders , Fifth Edition PDF
$ 40.00
Commentary: Concerns Regarding the Inclusion of Temper Dysregulation Disorder With Dysphoria in the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition PDF quantity
$ 40.00
×
Association Between Patient Beliefs Regarding Assigned Treatment and Clinical Response: Reanalysis of Data From the Hypericum Depression Trial Study Group PDF
$ 40.00
Association Between Patient Beliefs Regarding Assigned Treatment and Clinical Response: Reanalysis of Data From the Hypericum Depression Trial Study Group PDF quantity
$ 40.00
×
Toward a Definition of “No Meaningful Benefit” From Antidepressant Treatment: An Equipercentile Analysis With Cross-Trial Validation Across Multiple Rating Scales PDF
$ 40.00
Toward a Definition of “No Meaningful Benefit” From Antidepressant Treatment: An Equipercentile Analysis With Cross-Trial Validation Across Multiple Rating Scales PDF quantity
$ 40.00
×
Examining the Comorbidity of Bipolar Disorder and Autism Spectrum Disorders: A Large Controlled Analysis of Phenotypic and Familial Correlates in a Referred Population of Youth With Bipolar I Disorder With and Without Autism Spectrum Disorders PDF
$ 40.00
Examining the Comorbidity of Bipolar Disorder and Autism Spectrum Disorders: A Large Controlled Analysis of Phenotypic and Familial Correlates in a Referred Population of Youth With Bipolar I Disorder With and Without Autism Spectrum Disorders PDF quantity
$ 40.00
×
Does the Therapy Manual or the Therapist Matter Most in Treatment of Obsessive-Compulsive Disorder? A Randomized Controlled Trial of Exposure With Response or Ritual Prevention in 118 Patients PDF
$ 40.00
Does the Therapy Manual or the Therapist Matter Most in Treatment of Obsessive-Compulsive Disorder? A Randomized Controlled Trial of Exposure With Response or Ritual Prevention in 118 Patients PDF quantity
$ 40.00
×
Divalproex Sodium in Substance Abusers With Mood Disorder. PDF
$ 40.00
Divalproex Sodium in Substance Abusers With Mood Disorder. PDF quantity
$ 40.00
×
Clinical Features of Depressed Children and Adolescents With Various Forms of Suicidality PDF
$ 40.00
Clinical Features of Depressed Children and Adolescents With Various Forms of Suicidality PDF quantity
$ 40.00
×
Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis PDF
$ 40.00
Risk of Irritability With Psychostimulant Treatment in Children With ADHD: A Meta-Analysis PDF quantity
$ 40.00
×
"Subthreshold" Depression: Is the Distinction Between Depressive Disorder Not Otherwise Specified and Adjustment Disorder Valid? PDF
$ 40.00
"Subthreshold" Depression: Is the Distinction Between Depressive Disorder Not Otherwise Specified and Adjustment Disorder Valid? PDF quantity
$ 40.00
×
Comparison of Pharmacokinetic Profiles of Brand-Name and Generic Formulations of Citalopram and Venlafaxine: A Crossover Study PDF
$ 40.00
Comparison of Pharmacokinetic Profiles of Brand-Name and Generic Formulations of Citalopram and Venlafaxine: A Crossover Study PDF quantity
$ 40.00
×
New Coprescription of Opioids and Benzodiazepines and Mortality Among Veterans Affairs Patients With Posttraumatic Stress Disorder PDF
$ 40.00
New Coprescription of Opioids and Benzodiazepines and Mortality Among Veterans Affairs Patients With Posttraumatic Stress Disorder PDF quantity
$ 40.00
×
Adherence Assessments and the Use of Depot Antipsychotics in Patients With Schizophrenia. PDF
$ 40.00
Adherence Assessments and the Use of Depot Antipsychotics in Patients With Schizophrenia. PDF quantity
$ 40.00
×
Pimavanserin: A 2019 Clarification on the FDA Update PDF
$ 40.00
Pimavanserin: A 2019 Clarification on the FDA Update PDF quantity
$ 40.00
×
Clozapine-Induced Agranulocytosis in Finland, 1982-2007: Long-Term Monitoring of Patients Is Still Warranted PDF
$ 40.00
Clozapine-Induced Agranulocytosis in Finland, 1982-2007: Long-Term Monitoring of Patients Is Still Warranted PDF quantity
$ 40.00
×
A Survey of Sleep Quality in Patients With 13 Types of Mental Disorders PDF
$ 40.00
A Survey of Sleep Quality in Patients With 13 Types of Mental Disorders PDF quantity
$ 40.00
×
A Clinical Perspective of Attention-Deficit/Hyperactivity Disorder Into Adulthood PDF
$ 40.00
A Clinical Perspective of Attention-Deficit/Hyperactivity Disorder Into Adulthood PDF quantity
$ 40.00
×
Cognitive Change in the Year After a First Manic Episode: Association Between Clinical Outcome and Cognitive Performance Early in the Course of Bipolar I Disorder PDF
$ 40.00
Cognitive Change in the Year After a First Manic Episode: Association Between Clinical Outcome and Cognitive Performance Early in the Course of Bipolar I Disorder PDF quantity
$ 40.00
×
Substance Use Disorders in Individuals With Body Dysmorphic Disorder PDF
$ 40.00
Substance Use Disorders in Individuals With Body Dysmorphic Disorder PDF quantity
$ 40.00
×
Impulse-Control Disorders in a College Sample: Results From the Self-Administered Minnesota Impulse Disorders Interview (MIDI) PDF
$ 40.00
Impulse-Control Disorders in a College Sample: Results From the Self-Administered Minnesota Impulse Disorders Interview (MIDI) PDF quantity
$ 40.00
×
A Pilot Study of Barriers to Medication Adherence in Schizophrenia PDF
$ 40.00
A Pilot Study of Barriers to Medication Adherence in Schizophrenia PDF quantity
$ 40.00
×
Generalizability of Clinical Trial Results for Major Depression to Community Samples: Results From the National Epidemiologic Survey on Alcohol and Related Conditions PDF
$ 40.00
Generalizability of Clinical Trial Results for Major Depression to Community Samples: Results From the National Epidemiologic Survey on Alcohol and Related Conditions PDF quantity
$ 40.00
×
Comorbidity of Obsessive-Compulsive Disorder and Depression: Prevalence, Symptom Severity, and Treatment Effect PDF
$ 40.00
Comorbidity of Obsessive-Compulsive Disorder and Depression: Prevalence, Symptom Severity, and Treatment Effect PDF quantity
$ 40.00
×
Delusional Misidentification Post–Traumatic Brain Injury Responding to Clozapine PDF
$ 40.00
Delusional Misidentification Post–Traumatic Brain Injury Responding to Clozapine PDF quantity
$ 40.00
×
Acute Substance Use as a Warning Sign for Suicide Attempts: A Case-Crossover Examination of the 48 Hours Prior to a Recent Suicide Attempt PDF
$ 40.00
Acute Substance Use as a Warning Sign for Suicide Attempts: A Case-Crossover Examination of the 48 Hours Prior to a Recent Suicide Attempt PDF quantity
$ 40.00
×
The Diagnostic Challenge of Psychiatric Symptoms in Neurodegenerative Disease: Rates of and Risk Factors for Prior Psychiatric Diagnosis in Patients With Early Neurodegenerative Disease PDF
$ 40.00
The Diagnostic Challenge of Psychiatric Symptoms in Neurodegenerative Disease: Rates of and Risk Factors for Prior Psychiatric Diagnosis in Patients With Early Neurodegenerative Disease PDF quantity
$ 40.00
Coupon: Apply coupon
Update cart